BioStock: FDA clearance opens US market for BiBBInstruments

Report this content

Medtech company BiBBInstruments recently received 510(k) clearance from the FDA for its lead product, EndoDrill GI. Now, the company expects also a new market approval in Europe  –  a CE certificate according to MDR – for all products in the EndoDrill product portfolio within 3-6 months. BioStock contacted CEO Fredrik Lindblad for a comment. 

Read the interview with Fredrik Lindblad at biostock.se:

FDA clearance opens US market for BiBBInstruments - BioStock

This is a press release from BioStock - Connecting Innovation & Capital. https://www.biostock.se/en/

Subscribe

Documents & Links

Quick facts

BioStock: FDA clearance opens US market for BiBBInstruments
Tweet this